H G Klingemann

Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation.

D. Horsman, D E Horsman, T J Nevill, 1998, Blood.

Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.

T. Tonn, H G Klingemann, H. Klingemann, 1999, Human gene therapy.

1994 Consensus Conference on Acute GVHD Grading.

E D Thomas, D. Weisdorf, E. Thomas, 1995, Bone marrow transplantation.